Healthtech funding in 2021
European Healthtech startup funding raised during 2021.
In 2021, 586 European Healthtech companies closed 608 funding rounds and raised €9.5B in equity funding (excluding debt and grants). Debt rounds added €214M. UK led by capital raised, and Octopus Ventures was the most active investor. Data as of 18 Nov 2026.
Equity funding
€9.5B
excl. debt & grants · +€214M debt
Funding rounds
608
Companies
586
Top country
UK
Healthtech: last three years
change vs the year beforeRank among sectors
#5
6.7% of sector funding
Debt financing
€214M
2.2% of total
Top-10 round share
23.2%
of disclosed capital
Rounds ≥ €100M
18
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, 2021 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jan | €597M | 34 |
| Feb | €476M | 27 |
| Mar | €497M | 34 |
| Apr | €818M | 37 |
| May | €864M | 51 |
| Jun | €660M | 49 |
| Jul | €1.2B | 78 |
| Aug | €706M | 51 |
| Sep | €894M | 63 |
| Oct | €854M | 65 |
| Nov | €1.0B | 61 |
| Dec | €1.0B | 58 |
Top countries
by € raisedHealthtech — top countries by capital, 2021 — interactive chart.
Data table
| Healthtech — top countries by capital, 2021 | |
|---|---|
| UK | €3.5B |
| Germany | €1.2B |
| France | €931M |
| Switzerland | €788M |
| Sweden | €658M |
| Israel | €613M |
| Netherlands | €438M |
| Spain | €311M |
Stage mix
by € raisedHealthtech — stage mix, 2021 — interactive chart.
Data table
| Healthtech — stage mix, 2021 | |
|---|---|
| Other | €3.6B |
| Series B | €1.9B |
| Series D+ | €1.4B |
| Series C | €1.2B |
| Series A | €908M |
| Seed | €256M |
| Debt | €214M |
| Growth/Late | €99M |
| Crowdfunding | €27M |
| Pre-Seed | €19M |
| Grant | €4.6M |
| Early VC | €3.3M |
Exits & M&A
39 Acquisition · 4 IPO43 exits · €3.2B disclosed.
| Arvelle Therapeutics | Acquisition | Jan 2021 | €784M |
| Babylon | IPO | Jun 2021 | €470M |
| BenevolentAI | IPO | Dec 2021 | €435M |
| Current Health | Acquisition | Nov 2021 | €357M |
| Simbionix | Acquisition | Jul 2021 | €256M |
| Sanifit | Acquisition | Nov 2021 | €205M |
Largest equity rounds
by disclosed amount, 2021| Company | Stage | Date | Amount |
|---|---|---|---|
| CMR Surgical | Series D+ | Jul 2021 | €505M |
| Sotio Biotech | Other | Dec 2021 | €280M |
| Kry | Series D+ | Apr 2021 | €262M |
| Oxford Nanopore Technologies | Other | May 2021 | €225M |
| Quanta | Series D+ | Jun 2021 | €205M |
| Owkin | Other | Nov 2021 | €159M |
| Sword Health | Series D+ | Nov 2021 | €145M |
| DNA Script | Series C | Oct 2021 | €142M |
| Quell Therapeutics | Series B | Nov 2021 | €138M |
| Atai Life Sciences | Series D+ | Mar 2021 | €131M |
Largest debt rounds
debt financing, 2021; not in the equity total| Company | Stage | Date | Amount |
|---|---|---|---|
| Immunocore | Debt | Feb 2021 | €190M |
| Midiagnostics | Debt | Dec 2021 | €20M |
| Corticale | Debt | Aug 2021 | €2.0M |
| Premier IT | Debt | Jul 2021 | €1.2M |
| Swiss Motion Technologies | Debt | Jun 2021 | €455k |
Top investors
most active in 2021, by deal count- Octopus Ventures10 deals
- Verve Ventures9 deals
- European Innovation Council (EIC)7 deals
- Sofinnova Partners7 deals
- BGF6 deals
- Calm Storm Ventures6 deals
- High-Tech Gründerfonds (HTGF)6 deals
- Kurma Partners6 deals
- LSP6 deals
- Parkwalk Advisors6 deals
Source: Tech.eu Funding Explorer · data as of 18 Nov 2026 · licence CC BY 4.0 · Methodology